Filana Therapeutics, Inc. Fair Value Adjustment of Warrants
Filana Therapeutics, Inc. (FLNA) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-03-12
- Filana Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was $0.00.
- Filana Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $0.00.
- Filana Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-06-30 was $0.00.
- Filana Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-03-31 was $0.00.
- Filana Therapeutics, Inc. fair value adjustment of warrants for fiscal 2025 was $0.00.
- Filana Therapeutics, Inc. fair value adjustment of warrants for fiscal 2024 was -$108.18M.
- Filana Therapeutics, Inc. fair value adjustment of warrants for fiscal 2023 was $0.00.
- Filana Therapeutics, Inc. fair value adjustment of warrants for fiscal 2022 was $0.00.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | -$65.14M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | -$65.14M derived: sum of 3 quarters · filed 2026-03-12 | -$108.18M 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | -$65.14M derived: sum of 2 quarters · filed 2025-11-12 | -$108.18M 10-Q · filed 2025-11-12 | -$108.18M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -$65.14M 10-Q · filed 2025-08-14 | -$108.18M 10-Q · filed 2025-08-14 | -$108.18M derived: sum of 3 quarters · filed 2026-03-12 | -$108.18M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | -$43.04M 10-Q · filed 2025-05-08 | -$43.04M derived: sum of 2 quarters · filed 2026-03-12 | -$43.04M derived: sum of 3 quarters · filed 2026-03-12 | -$43.04M derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |